儿童脑动静脉畸形立体定向放射外科治疗的临床结局:系统评价与荟萃分析
该系统评价与荟萃分析纳入20项研究共1212例儿童脑动静脉畸形患者,评估单次立体定向放射外科(SRS)的临床结局。汇总数据显示完全闭塞率为65.9%(95%CI 60.5%-71.1%),总体并发症率8.0%(95%CI 5.1%-11.5%),其中新发神经功能缺损率3.1%、出血率4.2%。亚组分析未发现治疗方式、治疗年份、畸形团体积、剂量或随访时间对结果有显著影响。
要点
- 儿童脑动静脉畸形单次SRS完全闭塞率为65.9%(95%CI 60.5%-71.1%)。
- 总体并发症率8.0%,新发神经功能缺损3.1%,出血4.2%。
- 亚组分析未显示治疗方式、年份、体积、剂量或随访时间的显著差异。
核心结论
- 单次立体定向放射外科是儿童脑动静脉畸形的安全治疗选择,可实现较高的闭塞率和可接受的并发症率。
研究设计与样本
- 系统评价与荟萃分析,纳入20项研究共1212例儿童脑动静脉畸形患者,提取闭塞率、新发出血率、新发神经功能缺损率和死亡率等变量进行分析。
主要发现
- 完全闭塞率为65.9%(95%CI 60.5%-71.1%;I2=66.5%)。
- 总体并发症率(包括新发出血、新发神经功能缺损和死亡)为8.0%(95%CI 5.1%-11.5%;I2=66.4%)。
- 新发神经功能缺损率为3.1%(95%CI 1.3%-5.4%;I2=59.7%),新发出血率为4.2%(95%CI 2.5%-6.3%;I2=42.7%)。
- 按治疗方式(Gamma Knife与其他)、治疗年份(2000年前后)、中位畸形团体积(≥3 vs <3 cm3)、中位剂量(≥20 vs <20 Gy)或随访时间(≥36 vs <36个月)分组的亚组分析均未显示显著差异。
临床怎么用
- 对于儿童脑动静脉畸形,单次SRS可作为治疗选择之一,需权衡闭塞率与并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arteriovenous malformations (AVMs) in pediatric patients exhibit remarkable differences in terms of management and outcomes. Owing to a paucity of relevant data pertaining to AVMs in pediatric patients, special interest and investigation are required for an improved understanding of the available evidence by clinicians. OBJECTIVE: To determine the clinical outcomes of single-session stereotactic radiosurgery (SRS) for AVMs in pediatric patients. METHODS: A systematic literature review was performed to identify studies that reported the outcomes of SRS for AVMs in pediatric patients. Data pertaining to variables such as obliteration rate, post-SRS new hemorrhage rate, post-SRS new neurological deficit rate, and mortality rate were extracted and analyzed using meta-analysis techniques. RESULTS: Based on pooled data from 20 studies with 1212 patients, single-session SRS resulted in complete obliteration in 65.9% (95% confidence interval [CI], 60.5%-71.1%; I2 = 66.5%) patients. Overall complication rate (including new hemorrhage, new neurodeficit, and mortality) was 8.0% (95% CI, 5.1%-11.5%; I2 = 66.4%). Post-SRS new neurological deficit rate was 3.1% (95% CI, 1.3%-5.4%; I2 = 59.7%), and post-SRS hemorrhage rate was 4.2% (95% CI, 2.5%-6.3%; I2 = 42.7%). There was no significant difference between studies disaggregated by treatment method (Gamma Knife [Elekta AB] vs other), treatment year (before year 2000 vs after year 2000), median AVM volume reported (≥3 vs <3 cm3), median dose reported (≥20 vs <20 Gy), or follow-up period (≥36 vs <36 mo). CONCLUSION: Single-SRS is a safe treatment alternative that achieves high obliteration rates and acceptable complication rates for AVMs in pediatric patients.
引用
- Börcek AÖ, Çeltikçi E, Aksoğan Y, et al. Clinical Outcomes of Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations in Pediatric Patients: Systematic Review and Meta-Analysis. Neurosurgery. 2019. PMID: 31131849. doi:10.1093/neuros/nyz146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。